Ocular surface disease (OSD) is a prevalent yet frequently underrecognized challenge in the management of glaucoma. A significant overlap between glaucoma and dry eye disease (DED ...

The 2025 program built on its evolving reputation as a multispecialty educational forum that successfully integrates ophthalmology and optometry, premium CME content, and a family-friendly format to ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

Discussions from the EnVision Summit 2025 highlighted several clinical and surgical challenges that are expected to shape ...

Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell ...

This finding was based on the results of a study published in BMJ Open Ophthalmology1 that patients with diabetes who were ...

Edinburgh Biosciences has reported encouraging early outcomes from a structured long-term safety and performance follow-up ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...

Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...